US6303301B1
(en)
*
|
1997-01-13 |
2001-10-16 |
Affymetrix, Inc. |
Expression monitoring for gene function identification
|
US6355430B1
(en)
*
|
1998-12-24 |
2002-03-12 |
Millennium Pharmaceuticals, Inc. |
Diagnostic and screening methods employing KIAA0101
|
US6936424B1
(en)
|
1999-11-16 |
2005-08-30 |
Matritech, Inc. |
Materials and methods for detection and treatment of breast cancer
|
CN1425075A
(zh)
*
|
2000-02-22 |
2003-06-18 |
牛津生物医学(英国)有限公司 |
差异表达筛选方法
|
US6884578B2
(en)
|
2000-03-31 |
2005-04-26 |
Affymetrix, Inc. |
Genes differentially expressed in secretory versus proliferative endometrium
|
EP1282699B1
(de)
|
2000-05-04 |
2012-11-21 |
Sarepta Therapeutics, Inc. |
Spleisregion-antisensezusammensetzung und verfahren
|
US7700359B2
(en)
*
|
2000-06-02 |
2010-04-20 |
Novartis Vaccines And Diagnostics, Inc. |
Gene products differentially expressed in cancerous cells
|
WO2002002819A1
(en)
*
|
2000-06-30 |
2002-01-10 |
University Of Utah Research Foundation |
Method of screening for chemotherapeutic treatments for cancer
|
US7567870B1
(en)
|
2000-07-31 |
2009-07-28 |
Institute For Systems Biology |
Multiparameter analysis for predictive medicine
|
DE10037769A1
(de)
*
|
2000-08-03 |
2002-02-21 |
Epigenomics Gmbh |
Diagnose von mit CD24 assoziierten Krankheiten
|
US7807447B1
(en)
|
2000-08-25 |
2010-10-05 |
Merck Sharp & Dohme Corp. |
Compositions and methods for exon profiling
|
US6713257B2
(en)
*
|
2000-08-25 |
2004-03-30 |
Rosetta Inpharmatics Llc |
Gene discovery using microarrays
|
US7108969B1
(en)
*
|
2000-09-08 |
2006-09-19 |
Affymetrix, Inc. |
Methods for detecting and diagnosing oral cancer
|
GB0022978D0
(en)
|
2000-09-19 |
2000-11-01 |
Oxford Glycosciences Uk Ltd |
Detection of peptides
|
US6780594B2
(en)
|
2000-09-25 |
2004-08-24 |
Schering Aktiengesellschaft |
Method for in vitro diagnosis of endometriosis
|
DE10048633A1
(de)
*
|
2000-09-25 |
2002-04-18 |
Schering Ag |
Methode zur in vitro Diagnostik von Endometriose
|
US6743897B1
(en)
|
2000-11-27 |
2004-06-01 |
Cytokinetics, Inc. |
Aspergillus fumigatus profilin
|
US6403372B1
(en)
|
2000-11-27 |
2002-06-11 |
Cytokinetics, Inc. |
Aspergillus fumigatus profilin
|
DE60237917D1
(de)
*
|
2001-06-05 |
2010-11-18 |
Exelixis Inc |
Gfats als modifikatoren des p53-wegs und verwendungsverfahren
|
WO2002099134A1
(en)
*
|
2001-06-05 |
2002-12-12 |
Auckland Uniservices Limited |
Methods and compositions for assessment of pulmonary function and disorders
|
US20040214166A1
(en)
*
|
2001-06-08 |
2004-10-28 |
Xianqiang Li |
Method for identifying a disease state based on a detected mixture of activated transcription factors
|
US6696256B1
(en)
|
2001-06-08 |
2004-02-24 |
Pandmics, Inc. |
Method, array and kit for detecting activated transcription factors by hybridization array
|
US7981842B2
(en)
|
2001-06-08 |
2011-07-19 |
Panomics, Inc. |
Method for detecting transcription factor-protein interactions
|
US6924113B2
(en)
|
2001-06-08 |
2005-08-02 |
Panomics, Inc. |
Method and kit for isolating DNA probes that bind to activated transcription factors
|
US6821737B2
(en)
|
2001-06-08 |
2004-11-23 |
Panomics, Inc. |
Method for screening for drug candidates for modulating transcription factor activity
|
US7343247B2
(en)
*
|
2001-07-30 |
2008-03-11 |
The Institute For Systems Biology |
Methods of classifying drug responsiveness using multiparameter analysis
|
WO2003020930A1
(en)
*
|
2001-08-29 |
2003-03-13 |
The Board Of Trustees Of The University Of Illinois |
IDENTIFICATION AND USE OF MAMMALIAN p21 INHIBITORS
|
US7781413B2
(en)
*
|
2001-10-31 |
2010-08-24 |
Board Of Regents, The University Of Texas System |
SEMA3B inhibits tumor growth and induces apoptosis in cancer cells
|
CN1927466A
(zh)
*
|
2001-12-19 |
2007-03-14 |
阿菲梅特里克斯公司 |
阵列板和阵列板的构建方法
|
US20030175713A1
(en)
*
|
2002-02-15 |
2003-09-18 |
Clemens Sorg |
Method for diagnosis of inflammatory diseases using CALGRANULIN C
|
US20040096874A1
(en)
*
|
2002-04-11 |
2004-05-20 |
Third Wave Technologies, Inc. |
Characterization of CYP 2D6 genotypes
|
US7504215B2
(en)
|
2002-07-12 |
2009-03-17 |
Affymetrix, Inc. |
Nucleic acid labeling methods
|
CN1675374A
(zh)
*
|
2002-08-19 |
2005-09-28 |
阎云 |
肝脏疾病的治疗
|
AU2003295598B2
(en)
*
|
2002-11-15 |
2009-12-24 |
Genomic Health, Inc. |
Gene expression profiling of EGFR positive cancer
|
US20040231909A1
(en)
|
2003-01-15 |
2004-11-25 |
Tai-Yang Luh |
Motorized vehicle having forward and backward differential structure
|
WO2004071572A2
(en)
*
|
2003-02-06 |
2004-08-26 |
Genomic Health, Inc. |
Gene expression markers for response to egfr inhibitor drugs
|
ATE412779T1
(de)
*
|
2003-02-20 |
2008-11-15 |
Genomic Health Inc |
Benutzung von intronischen rna sequenzen zur quantifizierung der genexpression
|
JP2007506442A
(ja)
*
|
2003-05-30 |
2007-03-22 |
ゲノミック ヘルス, インコーポレイテッド |
Egfr阻害薬への応答に関する遺伝子発現マーカー
|
EP2327795B1
(de)
|
2003-06-10 |
2017-08-09 |
The Trustees Of Boston University |
Nachweismethoden für Lungenerkrankungen
|
ES2787475T3
(es)
|
2003-06-24 |
2020-10-16 |
Genomic Health Inc |
Predicción de probabilidad de recurrencia del cáncer
|
ES2905579T3
(es)
|
2003-07-10 |
2022-04-11 |
Genomic Health Inc |
Algoritmo del perfil de expresión y prueba para el pronóstico de la recaída del cáncer de mama
|
PE20050469A1
(es)
|
2003-09-18 |
2005-09-10 |
Lilly Co Eli |
Modulacion de la expresion de eif4e
|
JP2007509613A
(ja)
*
|
2003-10-16 |
2007-04-19 |
ジェノミック ヘルス, インコーポレイテッド |
遺伝子発現プロファイリングのためのqRT−PCRアッセイシステム
|
US20050196782A1
(en)
*
|
2003-12-23 |
2005-09-08 |
Kiefer Michael C. |
Universal amplification of fragmented RNA
|
EP1564306B1
(de)
|
2004-02-17 |
2013-08-07 |
Affymetrix, Inc. |
Verfahren zur Fragmentierung und Markierung von DNS
|
CN1957256B
(zh)
|
2004-03-24 |
2013-01-02 |
三路影像公司 |
用于子宫颈疾病检测的方法和组合物
|
EP2947160B1
(de)
|
2004-04-09 |
2017-07-12 |
Genomic Health, Inc. |
Genexpressionsmarker zur vorhersage der reaktion auf chemotherapie
|
EP1647600A3
(de)
|
2004-09-17 |
2006-06-28 |
Affymetrix, Inc. (A US Entity) |
Verfahren zur Kennzeichnung von biologischen Proben durch Hinzufügung von Nukleinsäre "bar-code" Markierungen
|
US20060068434A1
(en)
*
|
2004-09-21 |
2006-03-30 |
Jay Stoerker |
Methods and compositions for detecting cancer using components of the U2 spliceosomal particle
|
US20060073511A1
(en)
|
2004-10-05 |
2006-04-06 |
Affymetrix, Inc. |
Methods for amplifying and analyzing nucleic acids
|
ATE534905T1
(de)
*
|
2004-10-14 |
2011-12-15 |
Genentech Inc |
Cop1-moleküle und verwendungen davon
|
US7682782B2
(en)
|
2004-10-29 |
2010-03-23 |
Affymetrix, Inc. |
System, method, and product for multiple wavelength detection using single source excitation
|
CA2524964A1
(en)
|
2004-10-29 |
2006-04-29 |
Affymetrix, Inc. |
Automated method of manufacturing polymer arrays
|
ATE550440T1
(de)
*
|
2004-11-05 |
2012-04-15 |
Genomic Health Inc |
Molekulare indikatoren für brustkrebsprognose und vorhersage des ansprechens auf eine behandlung
|
AU2005304824B2
(en)
|
2004-11-05 |
2011-12-22 |
Genomic Health, Inc. |
Predicting response to chemotherapy using gene expression markers
|
US7957507B2
(en)
|
2005-02-28 |
2011-06-07 |
Cadman Patrick F |
Method and apparatus for modulating a radiation beam
|
EP3770278A1
(de)
|
2005-04-14 |
2021-01-27 |
The Trustees of Boston University |
Diagnose für lungenerkrankungen mittels klassenvorhersage
|
US20060269946A1
(en)
*
|
2005-05-10 |
2006-11-30 |
Young Robert P |
Methods and compositions for assessment of pulmonary function and disorders
|
US8232535B2
(en)
|
2005-05-10 |
2012-07-31 |
Tomotherapy Incorporated |
System and method of treating a patient with radiation therapy
|
PL1889065T3
(pl)
|
2005-05-18 |
2013-12-31 |
Novartis Ag |
Metody diagnostyki i leczenia chorób posiadających składnik autoimmunologiczny i/lub zapalny
|
CA2608161A1
(en)
*
|
2005-05-19 |
2006-11-23 |
Synergenz Bioscience Limited |
Methods for the assesssment of risk of developing lung cancer using analysis of genetic polymorphisms
|
JP2008545389A
(ja)
*
|
2005-05-19 |
2008-12-18 |
シナージェンズ バイオサイエンス リミティド |
肺機能及び肺障害の評価のための方法及び組成物
|
WO2006123943A1
(en)
*
|
2005-05-20 |
2006-11-23 |
Synergenz Bioscience Limited |
Methods of analysis of polymorphisms and uses thereof
|
ATE507879T1
(de)
*
|
2005-07-22 |
2011-05-15 |
Tomotherapy Inc |
System zur verabreichung einer strahlentherapie auf ein sich bewegendes zielgebiet
|
EP1907968A4
(de)
|
2005-07-22 |
2009-10-21 |
Tomotherapy Inc |
Verfahren und system zur bewertung von qualitätssicherheitskriterien bei der verabreichung eines behandlungsplans
|
JP2009507524A
(ja)
*
|
2005-07-22 |
2009-02-26 |
トモセラピー・インコーポレーテッド |
変形マップに制約を課す方法およびそれを実装するためのシステム
|
US7639854B2
(en)
*
|
2005-07-22 |
2009-12-29 |
Tomotherapy Incorporated |
Method and system for processing data relating to a radiation therapy treatment plan
|
US20070195922A1
(en)
*
|
2005-07-22 |
2007-08-23 |
Mackie Thomas R |
System and method of monitoring the operation of a medical device
|
EP1907066A4
(de)
*
|
2005-07-22 |
2009-10-21 |
Tomotherapy Inc |
System und verfahren zur verabreichung einer strahlentherapie auf ein sich bewegendes interessengebiet
|
EP1906827A4
(de)
*
|
2005-07-22 |
2009-10-21 |
Tomotherapy Inc |
System und verfahren zur evaluierung der mittels eines strahlungstherapiesystems verabreichten dosis
|
US7574251B2
(en)
*
|
2005-07-22 |
2009-08-11 |
Tomotherapy Incorporated |
Method and system for adapting a radiation therapy treatment plan based on a biological model
|
US8442287B2
(en)
|
2005-07-22 |
2013-05-14 |
Tomotherapy Incorporated |
Method and system for evaluating quality assurance criteria in delivery of a treatment plan
|
JP2009502257A
(ja)
*
|
2005-07-22 |
2009-01-29 |
トモセラピー・インコーポレーテッド |
デリバーされた線量を評価するための方法およびシステム
|
AU2006272821A1
(en)
|
2005-07-23 |
2007-02-01 |
Tomotherapy Incorporated |
Radiation therapy imaging and delivery utilizing coordinated motion of gantry and couch
|
US20070092891A1
(en)
*
|
2005-09-02 |
2007-04-26 |
Willey James C |
Methods and compositions for identifying biomarkers useful in diagnosis and/or treatment of biological states
|
US20070134690A1
(en)
*
|
2005-10-07 |
2007-06-14 |
Baylor Research Institute |
Diagnosis of systemic onset juvenile idiopathic arthritis through blood leukocyte microarray analysis
|
US7634363B2
(en)
|
2005-12-07 |
2009-12-15 |
Affymetrix, Inc. |
Methods for high throughput genotyping
|
WO2007067946A2
(en)
*
|
2005-12-07 |
2007-06-14 |
The Regents Of The University Of California |
Diagnosis and treatment of chronic lymphocytic leukemia (cll)
|
EP1969506A1
(de)
*
|
2005-12-13 |
2008-09-17 |
Erasmus University Medical Center Rotterdam |
Genetische hirntumor-markierer
|
KR20080094803A
(ko)
|
2006-01-27 |
2008-10-24 |
트리패스 이미징, 인코포레이티드 |
난소암의 발병 가능성이 높은 환자를 확인하는 방법 및 그의 조성물
|
CA2645310A1
(en)
|
2006-03-09 |
2007-09-13 |
The Trustees Of Boston University |
Diagnostic and prognostic methods for lung disorders using gene expression profiles from nose epithelial cells
|
WO2007109376A2
(en)
|
2006-03-23 |
2007-09-27 |
Novartis Ag |
Anti-tumor cell antigen antibody therapeutics
|
CA2660286A1
(en)
|
2006-08-09 |
2008-02-21 |
Homestead Clinical Corporation |
Organ-specific proteins and methods of their use
|
WO2008024114A1
(en)
*
|
2006-08-24 |
2008-02-28 |
Genizon Biosciences Inc. |
Genemap of the human genes associated with schizophrenia
|
WO2008048986A2
(en)
*
|
2006-10-17 |
2008-04-24 |
Children's Hospital Medical Center |
Gene array technique for predicting response in inflammatory bowel diseases
|
US9845494B2
(en)
|
2006-10-18 |
2017-12-19 |
Affymetrix, Inc. |
Enzymatic methods for genotyping on arrays
|
NZ588574A
(en)
|
2006-11-03 |
2012-07-27 |
Baylor Res Inst |
Diagnosis of metastatic melanoma and monitoring indicators of immunosuppression through blood leukocyte microarray analysis
|
US8293684B2
(en)
*
|
2006-11-29 |
2012-10-23 |
Exiqon |
Locked nucleic acid reagents for labelling nucleic acids
|
US8200440B2
(en)
*
|
2007-05-18 |
2012-06-12 |
Affymetrix, Inc. |
System, method, and computer software product for genotype determination using probe array data
|
EP2253713B1
(de)
|
2008-03-11 |
2015-02-25 |
National Cancer Center |
Verfahren zur messung von kopiezahlen von chromosomen, genen oder speziellen nukleotidsequenzen mithilfe eines snp-arrays
|
GB0809069D0
(en)
|
2008-05-19 |
2008-06-25 |
Univ Leuven Kath |
Gene signatures
|
JP5740302B2
(ja)
|
2008-05-30 |
2015-06-24 |
ザ ユニバーシティー オブ ノースカロライナ アット チャペル ヒル |
乳癌の予後を予測するための遺伝子発現プロフィール
|
CN104830812B
(zh)
|
2009-03-16 |
2017-09-05 |
盘古生物制药有限公司 |
包含具有非经典生物活性的组氨酰‑tRNA合成酶剪接变异体的组合物及方法
|
WO2010120509A2
(en)
|
2009-03-31 |
2010-10-21 |
Atyr Pharma, Inc. |
Compositions and methods comprising aspartyl-trna synthetases having non-canonical biological activities
|
HUE026447T2
(en)
|
2009-10-16 |
2016-05-30 |
Novartis Ag |
Pharmacodynamic tumor response biomarkers
|
EP2496944A2
(de)
|
2009-11-05 |
2012-09-12 |
Novartis AG |
Prädiktive biomarker für die progression von fibrose
|
US8501122B2
(en)
|
2009-12-08 |
2013-08-06 |
Affymetrix, Inc. |
Manufacturing and processing polymer arrays
|
US8835358B2
(en)
|
2009-12-15 |
2014-09-16 |
Cellular Research, Inc. |
Digital counting of individual molecules by stochastic attachment of diverse labels
|
BR112012015693A8
(pt)
|
2009-12-23 |
2018-06-26 |
Hills Pet Nutrition Inc |
métodos para diagnosticar uma doença renal em um canino, para tratar melhorar ou atrasar a progressão de uma doença renal, sonda de ácido nucléico, e, uso de uma sonda
|
MX2012009318A
(es)
|
2010-02-10 |
2012-09-07 |
Novartis Ag |
Metodos y compuestos para el crecimiento muscular.
|
US8383793B2
(en)
|
2010-04-15 |
2013-02-26 |
St. Jude Children's Research Hospital |
Methods and compositions for the diagnosis and treatment of cancer resistant to anaplastic lymphoma kinase (ALK) kinase inhibitors
|
WO2011139714A2
(en)
|
2010-04-26 |
2011-11-10 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-trna synthetase
|
AU2011248614B2
(en)
|
2010-04-27 |
2017-02-16 |
Pangu Biopharma Limited |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl tRNA synthetases
|
WO2011139853A2
(en)
|
2010-04-28 |
2011-11-10 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl trna synthetases
|
US9068177B2
(en)
|
2010-04-29 |
2015-06-30 |
Atyr Pharma, Inc |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutaminyl-tRNA synthetases
|
CA2797374C
(en)
|
2010-04-29 |
2021-02-16 |
Pangu Biopharma Limited |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of asparaginyl trna synthetases
|
EP2563383B1
(de)
|
2010-04-29 |
2017-03-01 |
Atyr Pharma, Inc. |
Innovative entdeckung therapeutischer, diagnostischer und antikörperhaltiger zusammensetzungen im zusammenhang mit proteinfragmenten von valyl-trna-synthetasen
|
WO2011139986A2
(en)
|
2010-05-03 |
2011-11-10 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of arginyl-trna synthetases
|
JP6008841B2
(ja)
|
2010-05-03 |
2016-10-19 |
エータイアー ファーマ, インコーポレイテッド |
メチオニルtRNA合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見
|
CA2797977C
(en)
|
2010-05-03 |
2019-08-20 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-trna synthetases
|
EP2566499B1
(de)
|
2010-05-04 |
2017-01-25 |
aTyr Pharma, Inc. |
Innovative entdeckung therapeutischer, diagnostischer und antikörperhaltiger zusammensetzungen im zusammenhang mit proteinfragmenten aus einem p38-multi-trna-synthetase-komplex
|
CA2799197C
(en)
|
2010-05-14 |
2019-10-29 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-trna synthetases
|
CA2799480C
(en)
|
2010-05-17 |
2020-12-15 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-trna synthetases
|
WO2011150400A1
(en)
*
|
2010-05-28 |
2011-12-01 |
New York Blood Center, Inc. |
Nuclear scaffold protein stip/tfip11 target for cancer therapy
|
US8962560B2
(en)
|
2010-06-01 |
2015-02-24 |
Atyr Pharma Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Lysyl-tRNA synthetases
|
MY191929A
(en)
|
2010-06-03 |
2022-07-18 |
Pharmacyclics Llc |
The use of inhibitors of bruton's tyrosine kinase (btk)
|
CN103119176A
(zh)
|
2010-06-07 |
2013-05-22 |
霍夫曼-拉罗奇有限公司 |
用于预测对白介素-6受体抑制性单克隆抗体药物治疗的响应的基因表达标记
|
CN103118695B
(zh)
|
2010-07-12 |
2016-08-03 |
Atyr医药公司 |
与甘氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的发现
|
CN103167876B
(zh)
|
2010-08-12 |
2016-08-31 |
菲特治疗公司 |
改进的造血干细胞和祖细胞疗法
|
EP2608801B1
(de)
|
2010-08-25 |
2019-08-21 |
aTyr Pharma, Inc. |
Innovative erkennung therapeutischer, diagnostischer und antikörperhaltiger zusammensetzungen in zusammenhang mit proteinfragmenten von tyrosyl-trna-synthetasen
|
WO2012068170A2
(en)
|
2010-11-15 |
2012-05-24 |
Jau-Nan Lee |
Generation of neural stem cells from human trophoblast stem cells
|
EP2561102A1
(de)
|
2010-12-02 |
2013-02-27 |
Katholieke Universiteit Leuven K.U. Leuven R&D |
Eingriffe und diagnosen in zusammenhang mit der il-rezeptor-assoziierten kinase
|
US9255296B2
(en)
|
2011-02-24 |
2016-02-09 |
Hill's Pet Nutrition, Inc. |
Compositions and methods for diagnosing and treating kidney disorders in a feline
|
WO2012119077A1
(en)
|
2011-03-02 |
2012-09-07 |
Morphotek Inc. |
Co -administration of eribulin and farletuzumab for the treatment of breast cancer
|
MY164530A
(en)
|
2011-03-02 |
2017-12-29 |
Berg Llc |
Interrogatory cell-based assays and uses thereof
|
US9066963B2
(en)
|
2011-03-15 |
2015-06-30 |
The University Of North Carolina At Chapel Hill |
Methods of treating breast cancer with anthracycline therapy
|
ES2731653T3
(es)
|
2011-03-18 |
2019-11-18 |
Eisai R&D Man Co Ltd |
Métodos y usos para predecir la respuesta a la eribulina
|
WO2012134813A1
(en)
|
2011-03-31 |
2012-10-04 |
St. Jude Children's Research Hospital |
Methods and compositions for identifying minimal residual disease in acute lymphoblastic leukemia
|
AU2012271528B2
(en)
|
2011-06-15 |
2015-06-25 |
Hill's Pet Nutrition, Inc. |
Compositions and methods for diagnosing and monitoring hyperthyroidism in a feline
|
CA2857597A1
(en)
|
2011-11-30 |
2013-06-06 |
AbbVie Deutschland GmbH & Co. KG |
Methods and compositions for determining responsiveness to treatment with a tnf-alpha inhibitor
|
EP2794649B1
(de)
|
2011-12-19 |
2016-04-27 |
Hill's Pet Nutrition, Inc. |
Zusammensetzungen und verfahren zur diagnose von schilddrüsenüberfunktion bei haustieren
|
ES2652136T3
(es)
|
2012-02-16 |
2018-01-31 |
Atyr Pharma, Inc. |
Histidil-tRNA sintetasas para tratar enfermedades autoinmunitarias e inflamatorias
|
EP2820174B1
(de)
|
2012-02-27 |
2019-12-25 |
The University of North Carolina at Chapel Hill |
Verfahren und verwendung für molekulare tags
|
US10941396B2
(en)
|
2012-02-27 |
2021-03-09 |
Becton, Dickinson And Company |
Compositions and kits for molecular counting
|
KR20200105524A
(ko)
|
2012-04-02 |
2020-09-07 |
버그 엘엘씨 |
조사적 세포 기반 분석 및 이의 사용
|
EP2834371B1
(de)
|
2012-04-05 |
2019-01-09 |
The Regents of The University of California |
Genexpressionspaneel für brustkrebsprognose
|
CN104704128A
(zh)
|
2012-05-22 |
2015-06-10 |
纳米线科技公司 |
预测乳腺癌结果的nano46基因和方法
|
EP2877598A1
(de)
|
2012-07-24 |
2015-06-03 |
Pharmacyclics, Inc. |
Mutationen im zusammenhang mit der resistenz gegenüber hemmern der bruton-tyrosinkinase (btk)
|
CA2892822C
(en)
|
2012-11-27 |
2023-08-08 |
Pontificia Universidad Catolica De Chile |
Compositions and methods for diagnosing thyroid tumors
|
WO2014085493A1
(en)
|
2012-11-30 |
2014-06-05 |
Jau-Nan Lee |
Methods of differentiating stem cells by modulating mir-124
|
US20140205613A1
(en)
|
2013-01-21 |
2014-07-24 |
Abbvie Inc. |
Anti-tnf and anti-il 17 combination therapy biomarkers for inflammatory disease
|
CN105027227B
(zh)
|
2013-02-26 |
2017-09-08 |
安科锐公司 |
电磁致动的多叶准直器
|
DK2962100T3
(da)
|
2013-02-28 |
2021-11-01 |
Caprion Proteomics Inc |
Tuberkulosebiomarkører og anvendelser deraf
|
US20150072021A1
(en)
|
2013-09-09 |
2015-03-12 |
British Columbia Cancer Agency Branch |
Methods and Kits for Predicting Outcome and Methods and Kits for Treating Breast Cancer with Radiation Therapy
|
KR102392423B1
(ko)
|
2013-10-02 |
2022-05-02 |
더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 |
Wnt 조성물 및 정제 방법
|
DK3110973T3
(da)
|
2014-02-27 |
2019-05-13 |
Univ Leuven Kath |
Oxidativt stress og kardiovaskulære sygdomshændelser
|
US10704097B2
(en)
|
2014-02-27 |
2020-07-07 |
Katholieke Universiteit Leuven |
Oxidative stress and cardiovascular disease events
|
US9885086B2
(en)
|
2014-03-20 |
2018-02-06 |
Pharmacyclics Llc |
Phospholipase C gamma 2 and resistance associated mutations
|
WO2015184461A1
(en)
|
2014-05-30 |
2015-12-03 |
Faruki Hawazin |
Methods for typing of lung cancer
|
WO2015191783A2
(en)
|
2014-06-10 |
2015-12-17 |
Abbvie Inc. |
Biomarkers for inflammatory disease and methods of using same
|
EP3210142B1
(de)
|
2014-10-24 |
2020-09-16 |
Koninklijke Philips N.V. |
Beurteilung der zellulären beta-tgf-signalisierungspfadaktivität mittels mathematischer modellierung der zielgenexpression
|
BR112017007962A2
(pt)
|
2014-10-24 |
2018-01-23 |
Koninklijke Philips Nv |
método implementado por computador, aparelho, mídia de armazenamento, programa de computador, kit, e, uso do kit
|
AU2015334841B2
(en)
|
2014-10-24 |
2022-02-03 |
Koninklijke Philips N.V. |
Medical prognosis and prediction of treatment response using multiple cellular signaling pathway activities
|
GB2548059B
(en)
|
2014-11-26 |
2020-09-02 |
Accelerated Biosciences Corp |
Induced hepatocytes and uses thereof
|
MX2017007707A
(es)
|
2014-12-12 |
2018-03-06 |
Medivation Prostate Therapeutics Llc |
Metodo para predecir respuesta a agentes terapeuticos de cancer de mama y metodo de tratamiento de cancer de mama.
|
US10392601B2
(en)
|
2014-12-19 |
2019-08-27 |
Vrije Universiteit Brussel |
In Vitro maturation of a mammalian cumulus oocyte complex
|
JP2016214239A
(ja)
*
|
2015-05-15 |
2016-12-22 |
国立大学法人高知大学 |
膵がんマーカー
|
WO2017019905A1
(en)
|
2015-07-28 |
2017-02-02 |
Otonomy, Inc. |
Treatment using truncated trk b and trk c antagonists
|
WO2017029215A1
(en)
|
2015-08-14 |
2017-02-23 |
Koninklijke Philips N.V. |
Assessment of nfkb cellular signaling pathway activity using mathematical modelling of target gene expression
|
JP6858783B2
(ja)
|
2015-10-18 |
2021-04-14 |
アフィメトリックス インコーポレイテッド |
一塩基多型及びインデルの複対立遺伝子遺伝子型決定
|
KR20170076480A
(ko)
|
2015-12-24 |
2017-07-04 |
삼성전자주식회사 |
Pint 유전자의 발현 저해제 또는 pint의 활성 저해제를 포함하는 조성물 및 그의 용도
|
WO2017176652A2
(en)
|
2016-04-04 |
2017-10-12 |
Sinopia Biosciences, Inc. |
Treating extrapyramidal syndrome using trapidil
|
CN109790583B
(zh)
|
2016-05-17 |
2023-08-25 |
基因中心治疗公司 |
对肺腺癌亚型分型的方法
|
CA3024744A1
(en)
|
2016-05-17 |
2017-11-23 |
Genecentric Therapeutics, Inc. |
Methods for subtyping of lung squamous cell carcinoma
|
EP3260552A1
(de)
|
2016-06-20 |
2017-12-27 |
Istituto Europeo di Oncologia (IEO) |
Verfahren und kits mit gensignaturen zur stratifizierung von brustkrebspatienten
|
WO2018013883A1
(en)
|
2016-07-14 |
2018-01-18 |
Caprion Proteomics Inc. |
Biomarkers of latent tuberculosis infection
|
EP3487874A1
(de)
|
2016-07-20 |
2019-05-29 |
Westfälische Wilhelms-Universität Münster |
Komplexspezifische standardisierung von immunologischen verfahren zur quantifizierung von s100a12
|
EP3655418A4
(de)
|
2017-06-22 |
2021-05-19 |
Triact Therapeutics, Inc. |
Verfahren zur behandlung von glioblastom
|
US11739386B2
(en)
|
2017-07-21 |
2023-08-29 |
Genecentric Therapeutics, Inc. |
Methods for determining response to PARP inhibitors
|
WO2019032525A1
(en)
|
2017-08-07 |
2019-02-14 |
Genecentric Therapeutics, Inc. |
PROCESS FOR SUBTYPING EPIDERMOID CARCINOMA OF HEAD AND NECK
|
EP3687501A4
(de)
|
2017-09-29 |
2021-06-23 |
Triact Therapeutics, Inc. |
Iniparib-formulierungen und verwendungen davon
|
EP3461915A1
(de)
|
2017-10-02 |
2019-04-03 |
Koninklijke Philips N.V. |
Beurteilung der aktivität von zellulären jak-stat1/2-signalisierungspfaden mittels mathematischer modellierung der zielgenexpression
|
EP3502279A1
(de)
|
2017-12-20 |
2019-06-26 |
Koninklijke Philips N.V. |
Beurteilung der aktivität von zellulären mapk-ap 1-signalisierungspfaden mittels mathematischer modellierung der zielgenexpression
|
WO2019178606A1
(en)
|
2018-03-16 |
2019-09-19 |
Gopath Laboratories Llc |
Methods for personalized detection of the recurrence of cancer or metastasis and/or evaluation of treatment response
|
CN113166767A
(zh)
|
2018-09-05 |
2021-07-23 |
马克思-德布鲁克-分子医学中心亥姆霍兹联合会 |
用于工程合成顺式调控dna的方法
|
CA3115922A1
(en)
|
2018-10-09 |
2020-04-16 |
Genecentric Therapeutics, Inc. |
Detecting cancer cell of origin
|
WO2020104482A1
(en)
|
2018-11-20 |
2020-05-28 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for predicting metastatic potential in patients suffering from sdhb-mutated paraganglioma
|
WO2021188611A1
(en)
|
2020-03-18 |
2021-09-23 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for treating subjects having a heterozygous alanine-glyoxylate aminotransferase gene (agxt) variant
|
EP3907301A1
(de)
|
2020-05-08 |
2021-11-10 |
Istituto Europeo di Oncologia S.r.l. |
Methoden und kits zur bestimmung des risikos eines erneuten auftretens von brustkrebs
|
WO2023122758A1
(en)
|
2021-12-22 |
2023-06-29 |
Cornell University |
Prognostic/predictive epigenetic breast cancer signature
|